QM · rank #13 · 2026-07-21
MKSI
NASDAQ · $23.06B (USD)
The exact numbers the algorithm saw.
| Momentum 12-1 Return from 12 months ago to 1 month ago. | +350.05% |
|---|---|
| ROE TTM Return on equity, trailing 12 months. | +12.7% |
| Profit margin Net profit margin, trailing 12 months. | +8.0% |
| Market cap (USD) Size filter: > $500M required. | $23.06B |
| Anchor (recent) Close on 2026-06-18 | $406.37 |
| Anchor (far) Close on 2025-06-20 | $90.29 |
The AI research card
Independent qualitative review of each pick before the order is placed. On the rare day the research service is unavailable, the paper book trades on the quant ranking alone and no card appears here.
Summary
MKS Instruments is a global supplier of enabling technologies, subsystems, and specialty chemistry critical to semiconductor and advanced electronics manufacturing, with roughly 40% of revenue from recurring services and consumables.
Rationale
The momentum_12_1 signal of 3.50 is reinforced by a concrete fundamental catalyst — Q1 2026 beat of $2.30 vs. $2.04 consensus, ~15% YoY revenue growth, and Q2 guidance stepping up to ~$1.20B — while ROE of 12.7% and 8% profit margins confirm the quality screen is not riding pure sentiment but reflects real earnings recovery tied to AI-driven semiconductor capex.
Material risks
- 1MKS carries sizable secured term loans ($2.5B USD + €0.6B EUR maturing 2029) that create meaningful leverage risk if the AI semiconductor capex cycle turns down before the company can delever, compressing the quality thesis from the balance sheet side.
- 2Tariff and trade-policy exposure on its expanded Malaysia and Thailand manufacturing footprint could disrupt cost structure and margin guidance, threatening the ~47% gross margin assumption underpinning Q2 and full-year estimates.
AI verdict council
Each pick is reviewed independently by 3 models before any order. 2 of 3 voted to proceed.